CB2 Insights Announces FY2018 Financial Results After Transformative Year CB2 Insights to Host Conference Call Wednesday, May 1 at 4pm Eastern TORONTO, April 30, 2019 (GLOBE NEWSWIRE) — CB2...

CB2 Insights Completes Reverse Take-over Transaction, to List on Canadian Securities Exchange Under Symbol “CBII” Leading Data Company Focused on Medical Cannabis to Commence Trading on March 6 TORONTO,...

CB2 Insights Closes Oversubscribed Private Placement Medical Cannabis Clinical Data Company Raises in Excess of C$5M led by Merida Capital Partners TORONTO, Feb. 22, 2019 (GLOBE NEWSWIRE) — MVC...

Sail Selected by the Association of Cannabis Specialists to Empower U.S. Physicians With Clinical Decision Support Platform CDS platform to be implemented across multiple states to provide medical cannabis...

Canna Care Docs Enters Canada With Virtual Clinician Platform for Medical Cannabis Sail Expands its US-based Healthcare Group Internationally to Connect Physicians and Patients Looking to Integrate Cannabis into...

Sail Cannabis Announces Acquisition of Medeval Corp o/a Cannacare Docs Following Closing of a Brokered Private Placement Led by Canaccord Genuity Corp TORONTO, ON / ACCESSWIRE / January 4,...